Group by:
Item Type |
DateNumber of items: 3.
Journal article
Stelzer, D.; Weber, A.; Ihle, F.; Matthes, S.; Ceelen, F.; Zimmermann, G.; Kneidinger, N.; Schramm, R.; Winter, H.; Zoller, M.; Vogeser, M.; Behr, J. und Neurohr, C.
(2018):
Posaconazole liquid vs tablet formulation in lung transplant recipients.
In: Mycoses, Vol. 61, No. 3: pp. 186-194
Stelzer, D.; Ihle, F.; Weber, A.; Kneidinger, N.; Ceelen, E.; Zimmermann, G.; Schramm, R.; Winter, H.; Frey, L.; Andraschko, M.; Vogeser, M.; Behr, J. und Neurohr, C.
(2016):
Posaconazol Tablets in Lung Transplant Recipients: Plasma Trough Levels and Influencing Factors.
In: Journal of Heart and Lung Transplantation, Vol. 35, No. 4: S310-S310
Stelzer, D.; Ihle, F.; Weber, A.; Kneidinger, N.; Zimmermann, G.; Ceelen, F.; Schramm, R.; Winter, H.; Frey, L.; Andraschko, M.; Vogeser, M.; Behr, J. und Neurohr, C.
(2016):
Impact Of Posaconazol Liquid Vs. Tablet Formulation On Plasma Trough Levels In Lung Transplant Recipients.
In: American Journal of Respiratory and Critical Care Medicine, Vol. 193
This list was generated on Sun Dec 8 01:55:32 2024 CET.